Clinical Trials in Brazil / NCT06424743
Recruiting Not applicable

Preference of Women With Fibromyalgia Undergoing a Three Different Volumes of Resistance Training

NCT06424743 · tracked via the Priya Life Science Brazil tracker
Phase
Not applicable
Started
2025-07-01
Last updated
2025-07-23

Condition(s) studied

Fibromyalgia, PrimaryChronic PainExercise Addiction

Investigational drug(s) / intervention(s)

exercise

exercise: exercise programs with different volumes

Study summary

Fibromyalgia is a painful syndrome of unknown etiology, which affects 2% of world population, with symptoms such as: pain, unrefreshing sleep, fatigue and mood disorders. It is already established in the literature that resistance training is part of the non- pharmacological treatment for patients with fibromyalgia. The big gap is about the quantity adequate and/or recommended exercise volume, despite some studies with exercise volumes different resistance trainings show improvements, we do not have a direction, besides We still do not know whether there is a preference for these patients in different resistance training volumes.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Women aged 18 to 65 * Have a diagnosis of fibromyalgia according to the ACR 2016 criteria Exclusion Criteria: * Have performed resistance training in the last 6 months * Having another associated rheumatic condition * Have a trip or appointment scheduled that requires absence for the next 4 (four) weeks from the start of the survey; * Women with musculoskeletal injuries in the upper and/or lower limbs * Have heart problems that prevent maximal efforts and submaximums

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Marcelo Cardoso de Souza Natal Rio Grande do Norte Recruiting

More Universidade Federal do Rio Grande do Norte trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06424743 on ClinicalTrials.gov ↗ ← All trials in Brazil